Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +61.61%
#3 DogBull DogBull +36.85%
#4 Ontology Gas Ontology Gas +32.12%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +22.27%
#7 Nockchain Nockchain +19.56%
#8 Unit Pump Unit Pump +18.85%
#9 Pump.fun Pump.fun +18.85%
#10 rsERG rsERG +18.40%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classement en actions #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prix de l'action
$0.12164306
Dernière synchronisation: 2024-11-11
Capitalisation boursière
$38.53M
Changement (1 jour)
-4.14%
Changement (1 an)
0.00%
Pays
AU
Échange PharmAust Limited (PAA)

Catégorie

Healthcare
EPS pour PharmAust Limited (PAA)
EPS au June 2024 TTM : $-0.01
Selon les derniers rapports financiers et le cours de l'action de PharmAust Limited, l’EPS actuel de la société (TTM) est de $-0.01. À la fin de 2023, la société avait un EPS de $-0.01 une diminution par rapport à celui de 2022, qui était de $0.00.
Historique de l'EPS de PharmAust Limited de 2001 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -148,134.19%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -237,194.02%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -25,570.09%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 68,105.13%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH